Researchers Uncover Heterogeneity of Tumor-Associated Macrophages in Colon Cancer
Research conducted at the Department of Oncology at Liuzhou People's Hospital in China has shed new light on the complex roles played by tumor-associated macrophages (TAMs) in colorectal cancer (CRC). According to a study published in the Journal of Inflammation Research, the researchers identified three distinct TAM subtypes with different functions in modulating tumor biology.
Key Takeaways:
- The study found that TAMs can be classified into three subtypes: CCL20+ TAMs with proinflammatory and anti-tumor properties, APOE+ TAMs with lipid-metabolism and pro-tumor properties, and SLC40A1+ TAMs with immunosuppressive and pro-tumor properties.
- The researchers used an integrated single-cell atlas of American and Asian studies to establish the TAM subtypes and their characteristics.
- The study revealed that APOE+ TAMs may be an intermediate state during macrophage polarization and contribute to a desmoplastic niche by promoting fibroblast-derived collagen pathways.
- SLC40A1+ TAMs may play an immunosuppressive role by promoting fibroblast-derived MIF pathways and the high expression of LGALS9.
- CRC with enriched CCL20+ and APOE+ TAMs were characterized by a high prevalence of deficient-mismatch repair (27.9%) and may achieve more benefit from immunotherapy.
Statistics:
- 27.9% of CRC patients with enriched CCL20+ and APOE+ TAMs had deficient-mismatch repair.
- The study utilized an integrated single-cell atlas of three American studies (GSE178341, GSE200997, and GSE231559) and five Asian studies (GSE132257, GSE132465, GSE144735, GSE221575, and GSE245552).
- The research concluded that this single-cell study established an accurate classification system of CRC TAMs, unveiling their diverse roles in modulating tumor biology and assisting in treatment options for CRC patients.
Sources:
- Xu, G., Fang, B., Tang, X., et al. (2025). Integrated Single-Cell Analysis Reveals the Heterogeneity of Tumor-Associated Macrophages and Their Implications for Immunotherapy in Colorectal Cancer. Journal of Inflammation Research, 2025, Volume 18(Issue 1):13381-13396. (Journal of Inflammation Research - http://www.dovepress.com/journal-of-inflammation-research-journal).